Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PanOptica
AddedFeb 15, 2024
UpdatedJun 18, 2026
PanOptica

PanOptica

Acquired

PanOptica, Inc.: A US-based bio-pharmaceutical firm specializing in ophthalmic therapeutics.

HQ
Mount Arlington, NJ, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

PanOptica, Inc., founded with a mission to revolutionize ophthalmic therapeutics, focuses on developing innovative treatments for serious eye diseases. The company aims to provide a more convenient and less invasive alternative to current intravitreal injection therapies by creating a topical eye drop solution. Their primary market includes patients suffering from neovascular eye diseases such as wet age-related macular degeneration (AMD).

Notable figures affiliated with PanOptica include Dr. Hemal Mehta, who provides expertise in the management of AMD. The company has garnered attention for its pioneering approach to reducing the treatment burden associated with current therapies. PanOptica's advancements have the potential to significantly impact patient care by offering a more accessible and patient-friendly treatment option for ocular diseases.

PanOptica - Similar Companies

Hyperion DeFi logo

Hyperion DeFi

eyenovia.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

EyeCyte logo

EyeCyte

eyecyte.com

Visiox logo

Visiox

visioxpharma.com

OcuTerra Therapeutics logo

OcuTerra Therapeutics

ocuterratx.com

Ocular Science logo

Ocular Science

ocularscience.com

TherOptix logo

TherOptix

OcuCure Therapeutics logo

OcuCure Therapeutics

Optherion logo

Optherion

optherion.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Neovista logo

Neovista

Vitreoretinal Technologies logo

Vitreoretinal Technologies

Optovue logo

Optovue

Phanes Therapeutics logo

Phanes Therapeutics

phanesthera.com

EyePoint logo

EyePoint

PanOptica - Quick Facts

Who are PanOptica's competitors?

Companies similar to PanOptica include Hyperion DeFi, Ocular Therapeutix, EyeCyte and Visiox.

When was PanOptica founded?

PanOptica was founded in 2009.

Where is PanOptica's headquarters located?

PanOptica's headquarters is located in Mount Arlington, NJ, US.

When was PanOptica's last funding round?

PanOptica's most recent funding round was for $11M (USD) in October 2017.

How much has PanOptica raised to-date?

As of Oct 6, 2017, PanOptica has raised a total of $109.9M (USD).

PanOptica - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Enterprise
Revenue
  • Licensing
  • Recurring
  • Software
Main Product
  • Eye Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 4772Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores
Show 20 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 456100Health and Personal Care Retailers
  • 325410Pharmaceutical and Medicine Manufacturing
  • 456110Pharmacies and Drug Retailers
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 8000Health Services
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 5912Drug Stores and Proprietary Stores
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified